Baxalta
GAMMAGARD S-D
Manufacturer:
Baxalta
Name:
GAMMAGARD S-D
HCPCS Code Descriptor:
Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
Category:
J Code
HCPCS:
J1566
NDC(s):
00944-2658-04, 00944-2656-03
Primary Type:
Immunoglobulin
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
GAMMAGARD S-D is an Immunoglobulin drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J1566 is aligned to the drug GAMMAGARD S-D.
Gammagard S/D is used to help protect people with weakened immune systems by increasing platelet count. Gammagard S/D can also be used to treat certain cases of muscle weakness, certain nerve disorders, and blood vessel disorders. Gammagard S/D is administered as an intravenous injection of human blood that contains a high level of antibodies. Gammagard Liquid, is a different product than Gammagard S/D. Gammagard S/D is mapped to the HCPCS J1566 while Gammagard Liquid is mapped to the HCPCS J1569. The product monograph for Gammagard S/D can be found through Takeda.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/06
HCPCS Effective Date:
1/1/08
HCPCS Short Description:
Immune globulin, powder
Billing and Coding Guide:
Not Found
Patient Assistance:
https://assets-dam.takeda.com/raw/upload/v1662721788/legacy-dotcom/siteassets/en-ca/home/what-we-do/our-medicines/product-monographs/gammagard-sd/gammagard-sd-pm-en.pdf